Increased arthritis risk estimates were apparent for all 3 autoantibody classes, but anti-CCP2 conferred the highest risk [hazard ratio (HR) 8.5], and was the only autoantibody remaining significant in multivariable analysis. The gene discussed is AGBL2; the disease is arthritic joint disease.